Allergan successfully completes Kythera acquisition
KYBELLA® first FDA-approved non-surgical injection for submental fullness bolsters Allergan’s world-class facial aesthetics portfolio
Read MoreTag: Submental Fat
ATX-101: Non-surgical reduction of submental fat
Klaus Hoffmann reviews the results of phase I, II, and III clinical studies using ATX-101 for the reduction of submental fat and discusses its potential use in clinical practice
Read MoreATX-101 shows further promise for reduction of chin fat in clinical trials
Skin laxity and fat build-up under the chin is a common concern among facial aesthetic patients. Although surgery has long...
Read MoreFirst topical pharmacologic therapy to enter clinical trials for ‘double chin’
Topokine Therapeutics has initiated dosing in a Phase 2, randomised controlled clinical trial of XAF5 Gel for reduction of excess...
Read More
March/April Issue
